Clinical Development Lead, Solid Tumor Oncology, BTC & GEA
Company: Jazz Pharmaceuticals
Location: Palo Alto
Posted on: April 17, 2024
|
|
Job Description:
If you are a Jazz employee please apply via the Internal Career
site
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global
biopharmaceutical company whose purpose is to innovate to transform
the lives of patients and their families. We are dedicated to
developing life-changing medicines for people with serious diseases
- often with limited or no therapeutic options. We have a diverse
portfolio of marketed medicines and novel product candidates, from
early- to late-stage development, in neuroscience and oncology. We
actively explore new options for patients including novel
compounds, small molecules and biologics, and through cannabinoid
science and innovative delivery technologies. Jazz is headquartered
in Dublin, Ireland and has employees around the globe, serving
patients in nearly 75 countries. For more information, please visit
www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.
Brief Description:
The Clinical Development Lead, Oncology, BTC (Biliary Tract Cancer)
and GEA (Gastroesophageal Adenocarcinoma) will lead the late-stage
development and life-cycle management of a key Oncology asset for
BTC and GEA. The Clinical Development Lead will play a pivotal role
in driving the Clinical Development strategy for BTC and GEA,
including new-related indications, working with a cross functional
matrix team to advance the development of a key Oncology asset
throughout the development life cycle through to commercialization.
The Clinical Development Lead will also be responsible for leading
a team of Medical Directors and Clinical Scientists.
Responsibilities include resource planning and allocation, budget
management and development of the team to instill a
high-performance culture driving the team to focus on positive
outcomes for the patients we serve.
Essential Functions/Responsibilities
Strategic Leadership: Provide strategic direction and leadership
for the clinical development of BTC and GEA Oncology program,
aligning with overall corporate goals and objectives.
Clinical Development Planning: Develop and execute comprehensive
Global clinical development plans for Oncology in the context of
BTC and GEA, including study design, protocol development, and
regulatory strategy for all geographies.
Cross-functional Collaboration: Collaborate closely with
cross-functional teams, including clinical pharmacology,
translational medicine, clinical operations, medical affairs,
regulatory affairs, and commercial, to ensure seamless execution of
clinical development programs.
Regulatory Compliance: Ensure compliance with regulatory
requirements and guidelines, working closely with regulatory
affairs to facilitate timely submissions and approvals.
Clinical Trial Oversight: Oversee the execution of clinical trials,
monitoring study progress, data quality, and patient safety
throughout all phases of development.
Data Analysis and Interpretation: Analyze clinical trial data and
collaborate with biostatisticians and clinical scientists to
interpret results, draw conclusions, and make informed decisions
regarding trial progression.
Risk Management: Proactively identify risks and issues related to
clinical development programs and develop mitigation strategies to
ensure successful outcomes.
External Collaboration: Cultivate and maintain relationships with
key opinion leaders, academic institutions, clinical investigators,
and collaborative partners to enhance scientific exchange and
advance the oncology pipeline.
Budget and Resource Management: Manage budget allocation and
resource planning for clinical development programs, optimizing
efficiency and maximizing return on investment.
People Development: Foster a high-performance culture based on
excellence, innovation, and accountability within the BTC and GEA
clinical development team, providing mentorship and professional
development opportunities to team members.
Required Knowledge, Skills, and Abilities
Demonstrable experience with leading the development of a Solid
Tumor Oncology asset successfully through late-stage development
resulting in approval and commercialization.
Proven experience with leading and developing high performing
clinical development teams.
Executive presence consistent with the level of the role, able to
confidently and concisely articulate complex insights and data to
executive level audiences both internally and externally.
Required/Preferred Education and Licenses
MD required. Board certified Oncologist preferred.
Higher postgraduate degree e.g., PhD preferred.
Clinical and/or development experience in solid tumor oncology,
such as BTC or Gastrointestinal cancers is preferred. ---
Jazz Pharmaceuticals is an equal opportunity/affirmative action
employer and all qualified applicants will receive consideration
for employment without regard to race, color, religion, sex,
national origin, disability status, protected veteran status, or
any characteristic protected by law.
FOR US-BASED CANDIDATES ONLY
Jazz Pharmaceuticals, Inc. is committed to fair and equitable
compensation practices and we strive to provide employees with
total compensation packages that are market competitive.
For this role, the full and complete base pay range is $0-$0.
Individual compensation paid within this range will depend on many
factors, including qualifications, skills, relevant experience, job
knowledge, and other pertinent factors. The goal is to ensure fair
and competitive compensation aligned with the candidate's expertise
and contributions, within the established pay framework and our
Total Compensation philosophy. Internal equity considerations will
also influence individual base pay decisions. This range will be
reviewed on a regular basis.
At Jazz, your base pay is only one part of your total compensation
package. The successful candidate may also be eligible for a
discretionary annual cash bonus or incentive compensation
(depending on the role), in accordance with the terms of the
Company's Global Cash Bonus Plan or Incentive Compensation Plan, as
well as discretionary equity grants in accordance with Jazz's Long
Term Equity Incentive Plan.
The successful candidate will also be eligible to participate in
various benefits offerings, including, but not limited to, medical,
dental and vision insurance, 401k retirement savings plan, and
flexible paid vacation. For more information on our Benefits
offerings please click here:
https://careers.jazzpharma.com/benefits
--s-p-m1--
By applying, you consent to your information being processed by
SonicJobs and transmitted to the Employer.
See Jazz Pharma Privacy Policy at
https://www.icims.com/legal/privacy-notice-website/ and SonicJobs
Privacy Policy at https://www.sonicjobs.com/us/privacy-policy and
Terms of Use at https://www.sonicjobs.com/us/terms-conditions
Keywords: Jazz Pharmaceuticals, Newark , Clinical Development Lead, Solid Tumor Oncology, BTC & GEA, Healthcare , Palo Alto, California
Click
here to apply!
|